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Objective: Social support may influence the seeking of
appropriate treatment. We examined social support and peripheral
arterial disease (PAD) severity as determinants of treatment for
PAD in younger and older patients. Methods: Consecutive PAD
patients (N=203) completed the Perceived Social Support Scale.
Treadmill-walking distance and ankle–brachial pressure index
(ABPI) were measured. The main outcome was invasive treatment
for PAD in the year following diagnosis. Results: During follow-
up, 48% of the patients underwent invasive treatment for PAD.0022-3999/06/$ – see front matter D 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.jpsychores.2006.07.013
4 Corresponding author. Department of Medical Psychology, Tilburg
University, Room P512, Warandelaan 2, PO Box 90153, 5000 LE Tilburg,
The Netherlands. Tel.: +31 134662715; fax: +31 134662370.
E-mail address: a.e.a.m.aquarius@uvt.nl (A.E. Aquarius).Younger patients (V64 years) tended to be more often invasively
treated as compared to older patients. In younger patients, a high
level of social support predicted invasive treatment above and
beyond PAD severity. In older patients, low ABPI predicted
invasive treatment. Conclusion: Younger patients with inadequate
social support may fail to seek appropriate treatment, suggesting
the need to consider psychosocial factors in optimizing treatment
of atherosclerotic vascular disease in this high-risk group.
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Peripheral arterial disease (PAD) is a marker of systemic
atherosclerosis and is associated with an increased risk of
stroke, myocardial infarction, and cardiovascular death [1,2]
as well as cardiovascular risk factors such as smoking,
diabetes, hypertension, and hyperlipidemia. Previous studies
have shown that 95% of PAD patients have at least one of
these risk factors [2]. Intermittent claudication, a common
symptom of PAD, can lead to impaired walking ability [3,4]
and poor quality of life [5]. Despite its deleterious effects,
PAD remains a relatively underdiagnosed and untreated
disease [6].
Both disease severity and patient-based characteristics
such as age influence treatment of PAD [7]. In youngerpatients, lifestyle or occupational performance can be
strongly affected by the presence of PAD [8,9]. Therefore,
it has been argued that invasive treatment is most suitable
for these patients [10]. Age has also been associated with
prognosis and hospital course in other cardiovascular patient
groups [11,12]. Elderly patients often have longer hospital
stays and poorer prognosis as compared with younger
patients [11].
Perceived social support may also influence the clinical
treatment of cardiovascular disease. Perceived social sup-
port denotes the appraisal and the evaluation of existing
social relationships [13], and the perception that support
would be available if needed [14]. It has been shown that
adequate functional support influences adherence to treat-
ment [15]. Social support may facilitate the process of
receiving medical care by stimulating patients to engage in
more healthy behaviours [16–18]. In cardiac patients,
inadequate functional support, such as low perceived social
support, has been associated with adverse clinical outcomes
and mortality [14,19]. In patients with carotid arteryearch 61 (2006) 739–745
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to invasive treatment of their condition [16]. Social isolation
is associated with cardiovascular events in cardiac patients
[20,21] and a lower ankle–brachial pressure index (ABPI) in
PAD patients [22].
Despite these findings, the role of social support in PAD
is largely unknown. Therefore, the aim of the present study
was to examine the relative effect of disease severity and
social support as determinants of invasive treatment in
younger and older patients in the year following diagnosis.
We hypothesized that higher levels of perceived social
support are associated with a greater likelihood of getting
invasive treatment in PAD patients.Method
Patients
Between September 2001 and March 2004, a total of
257 consecutive patients presenting with symptomatic PAD
were admitted to the vascular outpatient clinic of the
department of surgery at the St. Elisabeth Hospital in
Tilburg, the Netherlands. All patients were newly diag-
nosed with PAD, based on history, physical examination,
treadmill-walking distance, and ABPI. Six patients were
excluded from the study due to cognitive impairment
(2 patients), recent myocardial infarction, visual problems,
illness (flu), and participation in another study. Of the
remaining 251 patients, 203 (81%) agreed to participate.
No significant differences were found in age, sex, ABPI,
maximum walking distance (MWD), pain-free walking
distance (PFWD), cardiovascular risk factors, or comorbid-
ity between participants and nonparticipants. The study was
approved by the local ethics committee, and all patients
signed written, informed consent.Predictors
Disease severity
In all patients, the PFWD, MWD, and ABPI were
measured as indices of severity of PAD. The ABPI is
defined as the ratio of the ankle systolic blood pressure to the
brachial artery systolic blood pressure and has a normal
resting value of about 1.0 [3]. A value of b0.90 is 95%
sensitive to detect PAD [6,7] and has been shown to be a
strong predictor of cardiovascular disease and mortality [23].
Treadmill-walking tests were performed to determine
PFWD and MWD. Treadmill tests are widely used to obtain
objective information on walking ability of patients with
symptomatic PAD [24]. During the treadmill test, patients
had to walk 3.5 km/h on a 5% incline, with a maximum of
1000 m [25]. For diagnosis, the exercise had to provoke the
typical pain and show an ABPI drop of at least 20 mmHg on
the symptomatic leg side [26].Although the APBI is a sensitive measure of PAD
severity, it does not correlate well with functional limita-
tion measures such as PFWD and MWD in PAD pa-
tients [7]. Therefore, in the present study both the ABPI
and the indexes of walking distance were used to measure
disease severity.
Cardiovascular risk factors
In the present study, diabetes mellitus, smoking,
hypertension, hyperlipidemia, and cardiac, carotid, renal,
and pulmonary status were measured at baseline in all
patients according to the standards recommended by the
Society for Vascular Surgery/North American Chapter of
the International Society for Cardiovascular Surgery
(Appendix A) [26].
Social support
To assess perceived social support, the 12-item version
of the Perceived Social Support Scale-Revised [27] was
used. This self-report scale examines perceived availability
of social relationships and satisfaction with social support
[19]. A total score and three subscale scores addressing
social support from family, friends, and significant others
can be obtained [27]. Item examples are the following: bI get
the emotional help and support I need from my family Q and
bMy friends really try to help me.Q The item’s rating scale
varied from 1 (very strongly disagree) to 7 (very strongly
agree). In cardiac patients, reliability and validity were
good [27]. In the present study, the Cronbach’s alpha
coefficient was .92 for the total score, and .89, .96, and
.95 for the subscales support from partner, family, and
friends, respectively.
Invasive treatment of PAD
Invasive treatment of PAD, either endovascular or
surgical, was used as an endpoint in the present study.
The general treatment policy for patients with intermittent
claudication is merely conservative, i.e., unsupervised
exercise training, the advice to quit smoking, and anti-
platelet medication, which is prescribed all patients. How-
ever, this does not always lead to improvements in walking
distance. Invasive therapy is then considered. However, in
case of severe impairment, or when conservative treatment
is not expected to improve patient’s functioning, invasive
treatment is considered sooner, especially in younger
patients with more demanding lifestyles. During the 1-year
follow-up period, hospital admission was prospectively
examined using the patient records from the participat-
ing hospital. All patients who underwent invasive treat-
ment were hospitalized. Invasive procedures were carried
out in the St. Elisabeth Hospital. In case a patient would
have been admitted to another hospital, or abroad, this
information would be obtained from the patient records
of the St. Elisabeth Hospital. Patients who were not
Table 1





















Diabetes mellitus 39 (19%) 14% 24%
Tobacco use 111 (55%) 67% 43%
Hypertension 91 (45%) 33% 56%
Hyperlipidemia 105 (52%) 57% 47%
Cardiac status 61 (30%) 24% 36%
Carotid status 20 (10%) 10% 10%
Renal status 8 (4%) 1% 6%
Pulmonary status 17 (8%) 3% 14%
A.E. Aquarius et al. / Journal of Psychosomatic Research 61 (2006) 739–745 741hospitalized at all during the 1-year follow-up period were
considered event free. Patients were excluded from further
analyses if they were hospitalized for other reasons than
invasive treatment of PAD, such as coronary artery bypass
grafting, or died during follow-up. All patients were
followed up throughout the study period with regard to
hospital admission.
Statistical analyses
Chi-square tests (dichotomous variables) were used to
examine differences between patient groups. Logistic
regression analyses were used to examine the predictive
value of ABPI, PFWD, MWD, and cardiovascular risk
factors separately with regard to invasive treatment for PAD,
after controlling for age and sex. Therefore, ABPI, PFWD,
and MWD were dichotomized into low scores (first quartile)
vs. average or high scores. This led to a cutoff score of 0.51
for ABPI, and cutoff scores of 40 and 130 m for limited
PFWD and MWD, respectively. These cutoff scores are in
accordance with a previous study [28]. The cardiovascular
risk factors were dichotomized to absent or present. The total
score of the Perceived Social Support Scale was dichotom-
ized into high scores (high levels of social support; upper
tertile; cutoff score N67) vs. average or low scores. PFWD
and MWD were included in a logistic regression analysis
(forward conditional method) to determine which treadmill
walking distance measure was the best predictor of invasive
treatment. To examine whether the predictive values of
disease severity indices regarding invasive treatment were
age dependent, the interaction terms AgeABPI, and Age
Treadmill Walking Distance (either PFWD or MWD) were
analyzed. To examine the effect of high levels of perceived
social support in younger and older patients separately,
we included age, sex, ABPI, treadmill walking distance,
cardiovascular risk factors, and the Perceived Social Support
Scale score in multivariate logistic regression analyses (enter
method) with invasive treatment as the endpoint. Conserva-
tively treated patients were used as the reference group. All
statistical analyses were performed with the Statistical
Package for the Social Sciences (SPSS) version 12.0 (SPSS
Inc, Chicago, IL).Results
Of all symptomatic PAD patients, the majority (n=186;
92%) reported the classical symptoms of intermittent
claudication, such as cramping or painful aching in the legs
that starts after a certain walking distance and resolves
within a few minutes after the patient stops walking [9]. A
small group (n=17; 8%) reported atypical leg symptoms.
The mean age of the study sample was 64.5 years, and the
majority were men (63%) (Table 1). During the follow-up
period, 4 (2%) patients had died and were therefore
excluded from the study. Seven patients who werehospitalized for other reasons than invasive treatment of
PAD were also excluded, leaving 192 patients for further
analyses. After 1 year, 99 (52%) patients had received
conservative treatment, whereas 93 patients were treated
invasively for their PAD condition. Modes of invasive
treatment were percutaneous transluminal angioplasty (PTA;
58%), bypass surgery (11%), desobstruction (5%), endarter-
ectomy (2%), or combinations of these interventions (24%).
Disease severity and invasive treatment
Low ABPI was associated with invasive treatment during
follow-up [odds ratio (OR), 2.32; 95% confidence interval
(CI), 1.13–4.78; P=.022] after controlling for age and sex.
Limited PFWD (OR, 2.61; 95%CI, 1.28–5.30; P=.008) and
MWD (OR, 6.17; 95% CI, 2.70–14.07; Pb.0001) were also
associated with invasive treatment, controlling for age and
sex. Invasively treated patients had a shorter PFWD and
MWD (mean, 74 and 265 m) at baseline, as compared with
conservatively treated patients (mean, 151 and 472 m,
respectively). A logistic regression model indicated that
MWD, but not PFWD, remained as an independent
predictor of invasive treatment (Pb.001). Therefore, we
used MWD as an index of treadmill walking distance in
further analyses. None of the cardiovascular risk factors
predicted invasive treatment.
Age-related differences in invasive treatment
To examine whether the predictive value of ABPI/MWD
regarding invasive treatment were age dependent, the
interaction terms ABPI  Age and MWD  Age were
analyzed. Both the interaction ABPI  Age (Pb.0001) and
MWD  Age (Pb.0001) were significant. Given these age-
dependent effects of PAD severity as a predictor of invasive
A.E. Aquarius et al. / Journal of Psychosomatic Research 61 (2006) 739–745742treatment, subsequent analyses were performed in two age
groups of younger and older patients. Of the 203 patients,
99 (49%) were younger than 65 years (younger group),
whereas 104 (51%) were 65 years or older (older group).
Younger patients tended to be more often invasively treated
as compared to older patients; i.e., rate of invasive treatment
was 55% vs. 42%, respectively (P=.062). In younger
patients, modes of invasive treatment were PTA (n=33),
bypass surgery (n=8), desobstruction (n=3), or combina-
tions of interventions (n=8). Invasively treated older
patients received PTA (n=25), bypass surgery (n=2),
desobstruction (n=2), endarterectomy (n=3), or combina-
tions of interventions (n=9).
Social support and invasive treatment
Seventy-eight percent of the younger patients had a
partner vs. 54% of the older patients. In both age groups,
having a partner was not associated with invasive treatment.
In younger patients, a high level of social support and
limited MWD independently predicted invasive treatment
(Table 2). Because in the younger patient group only one
person had a positive renal status, this comorbidity factor
was excluded from the analysis. In older patients, invasive
treatment was determined by poor ABPI (Table 2).Table 2
Independent predictors of invasive treatment for PAD in younger vs. older
patients using multivariate logistic regression analysis
Independent predictors of invasive treatment OR 95% CI P
Younger patients
Agea 0.92 0.81–1.03 .152
Sex 0.61 0.17–2.20 .447
Ankle–brachial pressure index 0.83 0.17–4.14 .818
Maximum treadmill-walking distance 15.16 1.53–150.06 .020
Diabetes mellitus 1.89 0.34–10.55 .467
Tobacco use 2.10 0.66–6.65 .207
Hypertension 0.86 0.22–3.35 .833
Hyperlipidemia 0.92 0.29–2.93 .893
Cardiac status 1.87 0.44–7.92 .395
Carotid status 2.80 0.42–18.68 .289
Pulmonary status 2.20 0.09–51.71 .626
High levels of social support 5.44 1.64–18.02 .006
Older patients
Agea 1.01 0.89–1.09 .991
Sex 0.98 0.35–2.92 .758
Ankle–brachial pressure index 4.15 1.34–12.89 .014
Maximum treadmill-walking distance 2.35 0.76–7.27 .139
Diabetes mellitus 0.74 0.19–2.90 .663
Tobacco use 1.11 0.40–3.11 .844
Hypertension 0.38 0.13–1.13 .082
Hyperlipidemia 0.93 0.28–3.04 .898
Cardiac status 0.45 0.13–1.59 .215
Carotid status 1.71 0.21–13.80 .613
Renal status 5.54 0.69–44.66 .108
Pulmonary status 0.36 0.07–1.96 .238
High levels of social support 1.59 0.50–5.07 .429
a Age was entered as a continuous variable.
Fig. 1. Invasive treatment in younger patients (A) vs. older patients (B) as a
function of ABPI and social support at baseline. Number of patients are
presented on top of each bar.Subsequent analyses focused on the influence of the three
subscales of social support: support from family, friends,
and significant others. In the younger patients, support from
family independently predicted invasive treatment of PAD
during follow-up (OR, 3.55; 95%CI, 1.05–12.02; P=.042),
after controlling for disease severity and risk factors. In
older patients, none of the social support subscales were
related to invasive treatment.
Next, the percentage of patients with invasive treatment
was examined for younger and older patients separately as
a function of social support and ABPI (Fig. 1). Almost
80% of younger PAD patients with high levels of social
support were treated invasively for their atherosclerotic con-
dition vs. only 45% of the younger patients with rela-
tively poor social support (P=.004). Furthermore, while
more than 60% of the older patients with low ABPI were
treated invasively, only 32% of these patients received in-
A.E. Aquarius et al. / Journal of Psychosomatic Research 61 (2006) 739–745 743vasive treatment when their ABPI was relatively moderate
or high (P=.007).Discussion
The findings of the present study highlight the relative
effect of PAD severity and social support as determinants
of invasive treatment in younger and older PAD patients, in
the year following diagnosis. These findings indicate that
high levels of social support and limited MWD are the
main predictors of invasive treatment in younger patients.
Hence, younger patients with adequate levels of social sup-
port may feel encouraged to seek more appropriate treat-
ment for their symptoms.
Despite its deleterious effects, PAD remains a relatively
underdiagnosed and untreated disease [6]. Previously it has
been shown that PAD may cause significant impairments in
a patient’s lifestyle or occupation for which invasive
treatment may be considered [29]. Especially in younger
patients with demanding lifestyles, invasive treatment is
warranted [10]. This indicates that the clinical decision to
consider a patient for invasive treatment depends on more
than disease status. Therefore, examining patient-based
characteristics that are associated with invasive treatment
has become increasingly important.
The present study indicates the importance of perceived
social support in PAD. The mechanisms of socially
mediated behaviour change have been described in social
cognitive theory, e.g., verbal persuasion and vicarious
learning [30]. To promote health behaviour and prevent
disease progression, the influence of patient’s social net-
works should be taken into account [30]. Social support
makes it easier and more practical for patients to engage in
healthy behaviour [18] and may influence disease progres-
sion by moderating a patient’s behaviour [16]. In addition, it
may facilitate the process of receiving medical care and
diminish stressful factors [16–18]. Patients with high levels
of social support may feel encouraged to seek more rigorous
treatment for their symptoms. Although social support was
not associated with invasive treatment in older patients, it
has been shown that help from a social support network
with practical tasks may facilitate recovery after hospital-
ization [31]. It is important to note that in the present study,
having a partner was not related to invasive treatment for
PAD. Although subscale analyses in the younger patient
group indicated that support from family was independently
associated with invasive treatment, this effect may have
occurred due to chance because we did not correct for
multiple comparisons. It is primarily the combination of
support from friends, family, and significant others that
predicts invasive treatment for PAD.
In older patients, poor ABPI was associated with more
invasive treatment. This evidence suggests that both
disease severity and patient-based characteristics are taken
into account by the vascular surgeon in the decision toconsider a patient for invasive treatment. As has been
suggested previously, treatment should be individualized
based on the degree of lifestyle limitations that are
encountered by a patient [32]. Younger patients often have
a more demanding lifestyle than do elderly patients. In
combination with the possible risk of invasive treatment,
rigorous treatment may be more suitable for younger
patients [10]. The results from the present study support
this notion. Findings from our previous research in another
sample of PAD patients showed that impaired health status
independently predicted invasive treatment in these
patients [28]. This also indicates the importance of
accounting for patient-based psychological factors in
treatment of PAD.
With regard to disease severity, we found that limited
MWD was a strong predictor of invasive treatment for
PAD, both in the total study population and in the group of
patients younger than 65 years. Moreover, low ABPI was
an important predictor of invasive treatment in the elderly
patients. These findings are in line with previous studies
[7]. It has also been shown in other studies that low ABPI
was associated with cardiovascular mortality and morbidity
in PAD patients [33,34]. A longer follow-up period is
needed to obtain more information on morbidity and
mortality in the present study. Furthermore, our study did
not include asymptomatic PAD patients or patients with
chronic critical limb ischemia. This could make general-
ization of the results to other forms of PAD difficult.
Patients with PAD may be asymptomatic and have latent
disease [35]. These patients are often unaware of their
disease status and do not seek treatment for their condition.
Patients with chronic critical limb ischemia, a severe form
of PAD, are often elderly and frail, and their long-term
survival is worse than that of patients with intermittent
claudication [36].
Overall, the findings from the present study provide
evidence for the predictive value of perceived social
support, in addition to traditional clinical indicators, with
regard to invasive treatment of intermittent claudication in
younger patients. These results have implications for further
clinical research and practice. In order to provide optimal
treatment, some patients may need more intensive follow-up
or additional care. Results from the present research suggest
that additional care in these high-risk PAD patients may be
aimed at modifying psychological factors such as social
support. Findings from the Enhancing Recovery in Coro-
nary Heart Disease (ENRICHD) trial, in which cardiac
patients with low perceived social support received cogni-
tive behaviour therapy, indicated that social isolation had
improved after treatment [37]. Although the relative im-
provement was less than expected, these findings are
important since they indicate the possibility to change
perceived social support levels in high-risk patients. Future
studies should therefore examine possible behavioural
pathways, such as seeking treatment, through which social
support may influence adverse clinical outcomes.
A.E. Aquarius et al. / Journal of Psychosomatic Research 61 (2006) 739–745744In conclusion, younger PAD patients with inadequate
social support may fail to seek appropriate treatment,
indicating the need to consider psychological factors in
optimizing treatment of atherosclerotic vascular disease
in this high-risk group. Furthermore, social support may
influence the process of modifying atherosclerotic risk
factors, which is also an important aspect of treatment of
intermittent claudication [32]. In case of socially isolated
patients who may fail to seek appropriate treatment for
their condition, additional (practical) support is needed to
improve behaviour modification and treatment adherence,
or to arrange practical support during a patient’s recovery
from invasive treatment. Social support is an important
aspect that should be assessed in PAD patients, espe-
cially in the relatively younger patients with an atheroscle-
rotic condition.References
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Appendix A. Grading system for cardiovascular risk
factors according to the Society for Vascular Surgery/
North American Chapter of the International Society for
Cardiovascular Surgery [26]Diabetes:
0 = none
1 = adult onset; controlled by diet or oral agents
2 = adult onset, insulin controlled
3 = juvenile onset
Smoking:
0 = none or none for last 10 years
1 = none current, but smoked in last 10 years
2 = current (includes abstinence less than 1 year), less than
1 pack/day
3 = current, greater than 1 pack/day
Hypertension:
0 = none, diastolic pressure usually lower than 90 mmHg
1 = controlled with single drug
2 = controlled with two drugs
3 = requires more than two drugs or uncontrolled
Hyperlipidemia:
0 =cholesterol (low-density lipoprotein and total) and
triglyceride levels within normal limits for age
1 = mild elevation, controllable by diet
2 = requiring strict dietary control
3 = requiring dietary and drug control
Cardiac status:
0 = asymptomatic, normal ECG1 = asymptomatic, remote myocardial infarction (MI) by
history (N6 months), occult MI by ECG, or fixed defect
on dipyridamole thallium or similar scan
2 = any one of stable angina, no angina but significant
reversible perfusion defect on dipyridamole thallium
scan, significant silent ischemia (=1% of time) on
Holter monitoring, ejection fraction 25% to 45%,
controlled ectopy or asymptomatic arrhythmia, history
of congestive heart failure (CHF) that is now well
compensated for
3 = any one of unstable angina, symptomatic or poorly
controlled ectopy or arrhythmia, poorly compensated
or recurrent CHF, ejection fraction less than 25%, MI
within 6 months
Carotid disease:
0 = no symptoms, no evidence of disease
1 = asymptomatic but with evidence of disease determined
by duplex scan or other accepted noninvasive test
or arteriogram
2 = transient or temporary stroke
3 = completed stroke with permanent neurologic deficit or
acute stroke
Renal status (refers to stable levels, not transient drops or
elevations in response to intravenous medication, hydration,
or contrast media):
0 = no known renal disease, normal serum creatinine level
1 = moderately elevated creatinine level, as high as 2.4 mg/dl
2 = creatinine level, 2.5 to 5.9 mg/dl
3 = creatinine level N6.0 mg/dl, or on dialysis or with
kidney transplant
Pulmonary status:
0 = asymptomatic, normal chest X-ray film, pulmonary
function test (PFT) within 20% of predicted
1 = asymptomatic or mild dyspnea on exertion, mild
chronic parenchymal X-ray changes, PFT 65% to
80% of predicted
2 = between 1 and 3
3 = vital capacity less than 1.85 l, FEV1 less than 1.2 l or
less than 35% of predicted, maximal voluntary
ventilation less than 50% of predicted, Pco2 greater
than 45 mmHg, supplemental oxygen use medically
necessary, or pulmonary hypertension.
